Risk-characterization framework for decision-making at the food and drug administration
| Autor Corporativo: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Washington, DC :
National Academies Press
2011.
|
| Edición: | 1st ed |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622362306719 |
Tabla de Contenidos:
- ""Front Matter""; ""Preface""; ""Contents""; ""A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration""; ""Summary""; ""1 Introduction""; ""2 A Risk-Characterization Framework""; ""3 Case Study of a Mitigation-Selection Decision""; ""4 Case Study of a Targeting Decision""; ""5 Case Study of a Strategic-Investment Decision""; ""6 Case Study of a Targeting Decision That Spans Food and Drug Administration Centers""; ""7 Conclusions and Future Directions""
- ""Appendix A: Letter Report on the Development of a Model for Ranking FDA Product Categories on the Basis of Health Risks""""Appendix B: Statement of Task for the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II""; ""Appendix C: Scenarios Provided by the U.S. Food and Drug Administration to the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II""; ""Appendix D: Biographic Information on the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II""
- ""Appendix E: Factors Hypothesized as Important in Understanding Risk""
